Literature DB >> 29470248

Role of cardiovascular imaging in cardiac resynchronization therapy: a literature review.

Biagio Sassone1,2, Gaetano Nucifora3,4, Donato Mele5, Cinzia Valzania6, Giovanni Bisignani7, Giuseppe Boriani8.   

Abstract

: Cardiac resynchronization therapy (CRT) is an established treatment in patients with symptomatic drug-refractory heart failure and broad QRS complex on the surface ECG. Despite the presence of either mechanical dyssynchrony or viable myocardium at the site where delivering left ventricular pacing being necessary conditions for a successful CRT, their direct assessment by techniques of cardiovascular imaging, though feasible, is not recommended in clinical practice by the current guidelines. Indeed, even though there is growing body of data providing evidence of the additional value of an image-based approach as compared with routine approach in improving response to CRT, these results should be confirmed in prospective and large multicentre trials before their impact on CRT guidelines is considered.

Entities:  

Mesh:

Year:  2018        PMID: 29470248     DOI: 10.2459/JCM.0000000000000635

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  3 in total

Review 1.  Clinical applications of feature-tracking cardiac magnetic resonance imaging.

Authors:  Daniele Muser; Simon A Castro; Pasquale Santangeli; Gaetano Nucifora
Journal:  World J Cardiol       Date:  2018-11-26

2.  Analysis of Cardiac Dyssynchrony - An Unsolved Issue! How to improve selection and response to Cardiac Resynchronization Therapy?

Authors:  Eduardo Arrais Rocha
Journal:  Arq Bras Cardiol       Date:  2018-10       Impact factor: 2.000

3.  Circulating metabolite profiles to predict response to cardiac resynchronization therapy.

Authors:  Xue Gong; Zhonghan Sun; Zheyong Huang; Qian Zhou; Ziqing Yu; Xueying Chen; Wenqi Shao; Yan Zheng; Yixiu Liang; Shengmei Qin; Yangang Su; Junbo Ge
Journal:  BMC Cardiovasc Disord       Date:  2020-04-16       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.